Clinical Trials Update: June 13, 2005
Healthy Patient Studies Renal Artery Disease Cancer Prevention
(HealthDay News) -- Here are the latest clinical trials, courtesy of CenterWatch:
Healthy Patient Studies
Male and female patients with low left ventricular ejection fraction will be recruited to determine if Warfarin (with target INR of 2.75 + 0.25) is superior to aspirin (325 mg per day) in the prevention of all-cause mortality and stroke. Eligible participants must be 18 or older, must be taking ACE-inhibitor medications; if intolerant, must be on a study-approved medication regimen and must be willing to have monthly blood testing. Research site located in Worcester, Mass.
Renal Artery Disease
Comparison study of calcium acetate + atorvastatin and sevelamer +/- atorvastatin on cardiovascular calcification and phosphorus levels in patients with end-stage renal disease. Research site located in Hollywood, Fla.
Women at high risk for breast cancer are eligible for participation in this research study. Since breast cancer arises in the breast milk duct lining, this study will obtain breast duct cells from each participant using the technique of ductal lavage every six months for three years. Participants must be between ages 35-70, with intact nipples, have had a family history of breast cancer, and be available for five years. Research site located in Milwaukee, Wisc.
Copyright 2005 CenterWatch. All rights reserved.